Allison Boyle
Medical · Patchogue, NYNPI 1285988642
Payments from drug & device makers
Across 76 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$321
- AbbVie$293
- Amgen$198
- GSK$128
- Boehringer Ingelheim$122
- Novo Nordisk$122
- plus $458 from 15 others
What the payments were for
- Food & beverage$1,63099%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 15 | $321 |
| AbbVie | 13 | $293 |
| Amgen | 9 | $198 |
| GSK | 6 | $128 |
| Boehringer Ingelheim | 5 | $122 |
| Novo Nordisk | 6 | $122 |
| Sumitomo Pharma America, Inc. | 1 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Johnson & Johnson | 3 | $55 |
| Astellas Pharma US Inc | 2 | $49 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| AstraZeneca | 2 | $34 |
| Indivior Inc. | 1 | $26 |
| Alkermes, Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Althera Pharmaceuticals LLC | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Eisai Inc. | 1 | $12 |
| Pfizer | 1 | $12 |
How this compares
$1,642 in reported general payments places this provider in the 75th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $2,322 |
| SynthroidLevothyroxine Sodium | 12 | $630 |
| Levothyroxine Sodium | 33 | $456 |
| Rosuvastatin Calcium | 36 | $390 |
| Zolpidem Tartrate ErZolpidem Tartrate | 14 | $331 |
| Alprazolam | 47 | $294 |
| Omeprazole | 22 | $266 |
| Metoprolol Succinate | 18 | $226 |
| Zolpidem Tartrate | 38 | $210 |
| Trazodone Hcl | 11 | $172 |
| Simvastatin | 22 | $166 |
| Atorvastatin Calcium | 22 | $151 |
| Escitalopram Oxalate | 11 | $134 |
| Lisinopril | 17 | $112 |
| Amlodipine Besylate | 24 | $107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USABuprenorphine-Naloxone | $13 | $2,32219 claims |
| AbbVieSynthroid | $293 | $63012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,395 medical providers in New York.
Other medical in Patchogue
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.